Lung cancer is the number one cause of cancer-related deaths that chemoprevention should be developed. We recently identified dihydromethysticin (DHM) as a promising chemopreventive agent against tobacco carcinogen NNK-induced lung tumorigenesis. To probe its mechanisms and facilitate its translation, we investigated the structure-activity relationship (SAR) of DHM on NNK-induced DNA damage in A/J mice. Twenty-two DHM analogs were synthesized. Their activity in reducing NNK-induced DNA damage in the target lung tissues in A/J mice was evaluated. The unnatural enantiomer was identified to be more potent than the natural enantiomer. The methylenedioxy functional moiety did not tolerate modifications. The other functional groups (the lactone ring and the ethyl linker) can accommodate various modifications. Importantly, several analogs of high structural similarity to DHM showed distinct efficacy in reducing NNK-induced DNA damage. They can serve as in vivo chemical probes to elucidate the mechanisms of DHM in blocking NNK-induced lung carcinogenesis, particularly in defining the contribution of NNK-induced DNA damage-driven vs. DNA damage-independent mechanisms. Funding Information: The research reported in this publication was supported in part by the grants R01 CA193268 (CX) and R01 AT007395 (JL and CX) from National Institutes of Health, Frank Duckworth Endowment College of Pharmacy University of Florida (CX), and Startup Fund University of Florida Health Cancer Center (CX). Declaration of Interests: No potential conflicts of interest were disclosed by the other authors. Ethics Approval Statement: Approved by Institutional Animal Care and Use Committee at the University of Florida.